miR-221/222: promising biomarkers for breast cancer (Q38093079)

28 August 2017

title

miR-221/222: promising biomarkers for breast cancer (English)

1 reference

28 August 2017

0 references

1 reference

Wei-Xian Chen

1

1 reference

28 August 2017

Qing Hu

2

1 reference

28 August 2017

Man-Tang Qiu

3

1 reference

28 August 2017

Shan-Liang Zhong

4

1 reference

28 August 2017

Jin-Jin Xu

5

1 reference

28 August 2017

Jin-Hai Tang

6

1 reference

28 August 2017

Jian-Hua Zhao

7

1 reference

28 August 2017

publication date

27 March 2013

1 reference

28 August 2017

1 reference

28 August 2017

volume

34

1 reference

28 August 2017

issue

3

1 reference

28 August 2017

page(s)

1361-1370

1 reference

MicroRNAs: target recognition and regulatory functions

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0750-Y

microRNAs in cancer management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0750-Y

MicroRNAs and their target gene networks in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0750-Y

MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0750-Y

miR221/222 in cancer: their role in tumor progression and response to therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0750-Y

The miR-200 and miR-221/222 microRNA families: opposing effects on epithelial identity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0750-Y

Hallmarks of Cancer: The Next Generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0750-Y

MicroRNA-221/222 confers tamoxifen resistance in breast cancer by targeting p27Kip1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0750-Y

MicroRNA-221/222 negatively regulates estrogen receptor alpha and is associated with tamoxifen resistance in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0750-Y

MicroRNAs link estrogen receptor alpha status and Dicer levels in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0750-Y

Plasma miR-221 as a predictive biomarker for chemoresistance in breast cancer patients who previously received neoadjuvant chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0750-Y

Mechanisms of resistance to endocrine therapy in breast cancer: focus on signaling pathways, miRNAs and genetically based resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0750-Y

Differential expression of microRNA expression in tamoxifen-sensitive MCF-7 versus tamoxifen-resistant LY2 human breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0750-Y

Anti-microRNA-222 (anti-miR-222) and -181B suppress growth of tamoxifen-resistant xenografts in mouse by targeting TIMP3 protein and modulating mitogenic signal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0750-Y

MicroRNA cluster 221-222 and estrogen receptor alpha interactions in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0750-Y

Interactions between the estrogen receptor, its cofactors and microRNAs in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0750-Y

MicroRNA-221/222 confers breast cancer fulvestrant resistance by regulating multiple signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0750-Y

Estrogen receptor-beta and breast cancer: translating biology into clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0750-Y

Human epidermal growth factor receptor 2 status modulates subcellular localization of and interaction with estrogen receptor alpha in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0750-Y

TRPS1 targeting by miR-221/222 promotes the epithelial-to-mesenchymal transition in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0750-Y

Cross-talk between HER2 and MED1 regulates tamoxifen resistance of human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0750-Y

Senescence; an endogenous anticancer mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0750-Y

Alternative lengthening of telomeres pathway: recombination-mediated telomere maintenance mechanism in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0750-Y

Telomere dysfunction, genome instability and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0750-Y

A mammalian microRNA cluster controls DNA methylation and telomere recombination via Rbl2-dependent regulation of DNA methyltransferases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0750-Y

Oxidative DNA damage correlates with cell immortalization and mir-92 expression in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0750-Y

Telomerase redefined: integrated regulation of hTR and hTERT for telomere maintenance and telomerase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0750-Y

Downregulation of miR-138 is associated with overexpression of human telomerase reverse transcriptase protein in human anaplastic thyroid carcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0750-Y

Telomerase expression and telomere length in breast cancer and their associations with adjuvant treatment and disease outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0750-Y

Accuracy of telomerase in estimating breast cancer risk: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0750-Y

Genetic polymorphisms in telomere pathway genes, telomere length, and breast cancer survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0750-Y

miR-221 overexpression contributes to liver tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0750-Y

miR-221 and miR-222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27Kip1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0750-Y

A Pumilio-induced RNA structure switch in p27-3' UTR controls miR-221 and miR-222 accessibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0750-Y

miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0750-Y

MicroRNAs 221/222 and genistein-mediated regulation of ARHI tumor suppressor gene in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0750-Y

Blinded by the Light: The Growing Complexity of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0750-Y

MicroRNA regulation of autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0750-Y

Molecules and their functions in autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0750-Y

microRNA expression patterns reveal differential expression of target genes with age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0750-Y

MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0750-Y

Prolonged mammosphere culture of MCF-7 cells induces an EMT and repression of the estrogen receptor by microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0750-Y

MicroRNA-338 regulates local cytochrome c oxidase IV mRNA levels and oxidative phosphorylation in the axons of sympathetic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0750-Y

Caspases cleave and inhibit the microRNA processing protein DiGeorge Critical Region 8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0750-Y

Role of microRNAs in vascular diseases, inflammation, and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0750-Y

MicroRNA changes in human arterial endothelial cells with senescence: relation to apoptosis, eNOS and inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0750-Y

The NO cascade, eNOS location, and microvascular permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0750-Y

Regulation of the expression and activity of the antiangiogenic homeobox gene GAX/MEOX2 by ZEB2 and microRNA-221

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0750-Y

Cell-specific effects of miR-221/222 in vessels: molecular mechanism and therapeutic application

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0750-Y

A necessary role of miR-221 and miR-222 in vascular smooth muscle cell proliferation and neointimal hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0750-Y

Inflammation, inflammatory cells and angiogenesis: decisions and indecisions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0750-Y

microRNA-222 controls neovascularization by regulating signal transducer and activator of transcription 5A expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0750-Y

Endothelial enriched microRNAs regulate angiotensin II-induced endothelial inflammation and migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0750-Y

Microenvironmental regulation of epithelial-mesenchymal transitions in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0750-Y

MicroRNAs miR-221 and miR-222: a new level of regulation in aggressive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0750-Y

MicroRNA expression analysis in triple-negative (ER, PR and Her2/neu) breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0750-Y

The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0750-Y

Snail family regulation and epithelial mesenchymal transitions in breast cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0750-Y

Correlation between Slug transcription factor and miR-221 in MDA-MB-231 breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0750-Y

ERalpha signaling through slug regulates E-cadherin and EMT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0750-Y

Prognostic value of Dicer expression in human breast cancers and association with the mesenchymal phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0750-Y

Regulation of EMT by TGFβ in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0750-Y

MicroRNA-221-222 regulate the cell cycle in mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0750-Y

MiR-221 influences effector functions and actin cytoskeleton in mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0750-Y

miR-221 and miR-155 regulate human dendritic cell development, apoptosis, and IL-12 production through targeting of p27kip1, KPC1, and SOCS-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0750-Y

MiRNA expression analysis of cancer-associated fibroblasts and normal fibroblasts in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0750-Y

Molecular imaging of a cancer-targeting theragnostics probe using a nucleolin aptamer- and microRNA-221 molecular beacon-conjugated nanoparticle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0750-Y

Distinct expressions of microRNAs that directly target estrogen receptor α in human breast cancer

21 January 2018

1 reference

12 December 2020

PUMA is a novel target of miR-221/222 in human epithelial cancers.

1 reference

12 December 2020

MicroRNAs modulate the angiogenic properties of HUVECs

1 reference

12 December 2020

SnapShot: The epithelial-mesenchymal transition

1 reference

12 December 2020

Dicer dependent microRNAs regulate gene expression and functions in human endothelial cells

1 reference

12 December 2020

Peptide nucleic acids targeting miR-221 modulate p27Kip1 expression in breast cancer MDA-MB-231 cells

1 reference

12 December 2020

Differential recruitment of the mammalian mediator subunit TRAP220 by estrogen receptors ERalpha and ERbeta

1 reference

12 December 2020

Analysis of miR-221 and p27 expression in human gliomas.

1 reference

12 December 2020

10.1007/S13277-013-0750-Y

Identifiers

DOI

1 reference

Dimensions Publication ID

28 August 2017

1050698733

0 references

1 reference